US › Healthcare

SINTX Technologies Inc (SINT)

US · Healthcare · Medical Devices

$1.66-6.21%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$380,000
Revenue YoY
+3.0%
Net profit
$-2.8M
Profit YoY
-23.1%
EPS
$-0.70
EPS estimate
$-0.66
Net margin
-742.4%

EPS came in at -0.70 against a street estimate of -0.66 — a miss of 6.1%.

Key statistics

Market cap
$10.8M
Forward P/E
0.0
P/B
11.96
Book value
$0.22
EPS (TTM)
$-5.57
52-week high
$6.78
52-week low
$1.40
50-day MA
$1.91
200-day MA
$2.83
Beta
0.63

Analyst view

Analysts rate SINTX Technologies Inc a buy (1 buy, 1 hold, 0 sell out of 2) with an average price target of $9.12.

Shareholding

Insiders
23.79%
Institutions
6.98%

Largest institutional holders

FundStake
Veracity Capital LLC1.21%
Vanguard Group Inc0.70%
Geode Capital Management, LLC0.51%
Vanguard Fiduciary Trust Co0.37%
Vanguard Capital Management, LLC0.33%
XTX Topco Ltd0.27%
State Street Corp0.21%
DRW Securities, LLC0.19%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for SINTX Technologies Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.